Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001707822 | SCV000726336 | likely benign | not provided | 2020-08-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003103812 | SCV001016500 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-08-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001187322 | SCV001354092 | likely benign | Cardiomyopathy | 2018-11-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002385929 | SCV002689949 | likely benign | Cardiovascular phenotype | 2019-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004740369 | SCV005345311 | likely benign | RYR2-related disorder | 2024-03-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |